Host-Related Factors as Targetable Drivers of Immunotherapy Response in Non-Small Cell Lung Cancer Patients

Despite some significant therapeutic breakthroughs leading to immunotherapy, a high percentage of patients with non-small cell lung cancer (NSCLC) do not respond to treatment on relapse, thus experiencing poor prognosis and survival. The unsatisfying results could be related to the features of the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Baci, Denisa, Cekani, Elona, Imperatori, Andrea, Ribatti, Domenico, Mortara, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298844/
https://www.ncbi.nlm.nih.gov/pubmed/35874749
http://dx.doi.org/10.3389/fimmu.2022.914890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298844/
https://www.ncbi.nlm.nih.gov/pubmed/35874749
http://dx.doi.org/10.3389/fimmu.2022.914890

Ejemplares similares